CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

White Paper RWE needs in Oncology: Metastatic Non-Small Cell Lung (NSCL) Cancer

NSCL Cancer

REAL WORLD EVIDENCE NEEDS IN ONCOLOGY:
NSCL Cancer

White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid.

NSCLC’s complex nature, characterized by diverse pathological profiles and variable responses to treatments, underscores the need for ongoing research and innovation in treatment strategies.

OXON has analyzed the results of the studies presented at ESMO 2023, and in this white paper summarizes the latest developments offering a comprehensive view of the latest strategies and outcomes in NSCLC management. The goal is to bridge research with clinical practice, demonstrating how these insights could reshape treatment guidelines for NSCLC.

To download the white paper please complete the following form:

    Your details: Fields marked with an asterisk (*) are required.

    First Name*

    Last Name*

    Work Email address*

    Company*

    Department*

    Position*

    Country*

    As responsible for the processing of the personal data you provide, OXON informs you that your data will be processed in accordance with the provisions of the laws in force related to data protection and notably the General Data Protection Regulation 2016/679. Your data will be used to establish or maintain a business relationship and sending you communications about our services. The data will be kept as long as there is a legitimate interest. As a data subject, you will have the right to withdraw your consent at any time. You will also have the right to access, to rectify, to erase your personal data as well as the right to ask for its portability or the limitation of its processing.